JPMorgan Chase increases its holdings in Zai Lab (09688) by 1,183,100 shares at a price of approximately HK$24.56 per share.
According to the latest data from the Hong Kong Stock Exchange, on November 11, JPMorgan Chase increased its holdings in RemeGen (09688) by 1,183,100 shares, with a price per share of 24.5597 Hong Kong dollars, for a total amount of approximately 29.0566 million Hong Kong dollars.
According to the latest data from the Hong Kong Stock Exchange, on November 11th, JPMorgan Chase increased its holdings of ZAI LAB (09688) by 1.1831 million shares, with a price of 24.5597 Hong Kong dollars per share, totaling approximately 29.0566 million Hong Kong dollars. After the increase, the latest number of shares held is approximately 140 million shares, and the latest shareholding ratio is 14.01%.
Related Articles

MINSHENG EDU (01569): HKIAC makes a partial ruling ordering the respondent to fulfill the relevant terms of the SPA.

BRAINAURORA-B (06681) signs a brain health digital AI technology service cooperation agreement with Macau Mirror Lake Hospital.

China Securities Co., Ltd.: The spring market is expected to continue after the Spring Festival, it is recommended to hold onto stocks during the festival.
MINSHENG EDU (01569): HKIAC makes a partial ruling ordering the respondent to fulfill the relevant terms of the SPA.

BRAINAURORA-B (06681) signs a brain health digital AI technology service cooperation agreement with Macau Mirror Lake Hospital.

China Securities Co., Ltd.: The spring market is expected to continue after the Spring Festival, it is recommended to hold onto stocks during the festival.

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


